Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.5.3159

Relationship between Colonic Polyp Type and the Neutrophil/Lymphocyte Ratio as a Biomarker  

Karaman, Hatice (Department of Pathology, Kayseri Education and Research Hospital)
Karaman, Ahmet (Department of Gastroenterology, Erciyes University)
Erden, Abdulsamet (Department of Internal Medicine, Erciyes University)
Poyrazoglu, Orhan Kursat (Department of Gastroenterology, Erciyes University)
Karakukcu, Cigdem (Department of Clinical Biochemistry, Erciyes University)
Tasdemir, Arzu (Department of Pathology, Kayseri Education and Research Hospital)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.5, 2013 , pp. 3159-3161 More about this Journal
Abstract
Aim: We designed this study to investigate the neutrophil lymphocyte ratio as a biomarker in distinguishing colonic polyps which are neoplastic or non-neoplastic. Materials and Methods: One hundred and twenty-five patients with colonic polyps were enrolled into the study. The following data were obtained from a computerized patient registry database: mean platelet volume (MPV), uric acid (UA), platelet count (PC), alkaline phosphatase (ALP), gamma-glutamyl transpeptidase (GGT) and the neutrophil to lymphocyte ratio (NLR). Exclusion criteria were active infectious disease, hematological disorders, and malignancies. Colonic polyps divided into two groups as neoplastic polyps (tubular adenoma, villous adenoma, tubulovillous adenoma) and non-neoplastic polyps (hyperplastic polyps, inflammatory pseudopolyps etc). The relationship between colonic polyp type and NLR was evaluated with statistical analysis. Results: There were 67 patients (53.6%) with neoplastic and 58 (46.4%) patients with non-neoplastic polyps. Mean NLRs of neoplastic and non-neoplastic groups were respectively $3.32{\pm}2.54$ and $2.98{\pm}3.16$ (P<0.05). Conclusion: Although sensitivity and specificity are not high, NLR may be used as a biomarker of neoplastic condition of colonic polyps.
Keywords
Colon polyps; neutrophil to lymphocyte ratio; neoplastic polyps;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Al-Shaiba R, McMillan DC, Angerson WJ, et al (2004). The relationship between hypoalbuminaemia, tumour volume and the systemic inflammatory response in patients with colorectal liver metastases. Br J Cancer, 91, 205-7.
2 An X, Ding PR, Li YH, et al (2010). Elevated neutrophil to lymphocyte ratio predicts survival in advanced pancreatic cancer. Biomarkers, 15, 516-22.   DOI   ScienceOn
3 Cho H, Hur HW, Kim SW et al (2008). Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial ovarian cancer and predicts survival after treatment. Cancer Immunol Immunother, 58, 15-23.
4 Chua W, Charles KA, Baracos VE, et al (2011). Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer, 104, 1288-95.   DOI   ScienceOn
5 Correa P (1979). Epidemiology of polyps and cancer in the human intestine. Gastroenterology, 77, 1245-51.
6 Coussens LM, Werb Z (2002). Inflammation and cancer. Nature, 420, 860-7.   DOI   ScienceOn
7 Fenoglio CM, Pascal RR (1982). Colorectal adenomas and cancer: Pathologic relationships. Cancer, 50, 2601- 8.
8 Halazun KJ, Aldoori A, Malik HZ, et al (2008). Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol, 34, 55-60.   DOI   ScienceOn
9 Imtiaz F, Shafique K, Mirza SS et al (2012). Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Archives of Med. 5, 2.   DOI   ScienceOn
10 Ishizuka M, Nagata H, Takagi K, et al (2012). C-reactive protein is associated with distant metastasis of T3 colorectal cancer. Anticancer Res, 32, 1409-15.
11 Konishi F, Morson BC (1982). Pathology of colorectal adenomas: A colonoscopic survey. J Clin Pathol, 35, 830-41.   DOI
12 Linton A, Zandwijk N, Reid G, Stephen Clarke et al (2012). Inflammation in malignant mesothelioma - friend or foe?. Ann Cardiothorasic Surg, 1, 516-22.
13 Mc Millan DC, Canna K, Mc Ardle CS (2003). Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg, 90, 215-9.   DOI   ScienceOn
14 Morson BC (1966). Factors influencing the prognosis of early cancer of the rectum. Proc R Soc Med, 59, 607-8.
15 Pages F, Berger A, Camus M, et al (2005). Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med, 353, 2654-66.   DOI   ScienceOn
16 Saito K, Kihara K (2010). Role of C-reactive protein as a biomarker for renal cell carcinoma. Expert Rev Anticancer Ther, 10, 1979-89   DOI   ScienceOn
17 Ubukata H, Motohashi G, Tabuchi T, et al (2010). Evaluations of interferon-$\gamma$/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol, 102, 742-7.   DOI   ScienceOn
18 Ueno H, Hawrylowicz CM, Banchereau J (2007). Immunological intervention in human diseases. J Transl Med, 5, 59.   DOI   ScienceOn
19 Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ (2005). Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol, 91, 181-4   DOI   ScienceOn